First identified as an oncogene in melanoma for its ability to activate MAPK pathway and induce tumor cell migration and proliferation [218,219], BANCR has also been reported as tumor suppressor in NSCLC for its role in epithelial-mesenchymal transition (EMT) [220]. Here, BANCR is linked to neoplasm.